Related Experiment Video
Updated: Apr 30, 2026
09:44
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
10.7K
Gross hepatic changes in developing albino rats exposed to valproic acid
Summary
Valproic acid (VPA) exposure during pregnancy significantly reduces fetal rat liver weight and relative tissue weight. Careful consideration of VPA use in pregnancy is crucial due to potential hepatotoxicity in developing fetuses.
Area of Science:
- Toxicology
- Developmental Biology
- Pharmacology
Background:
- Valproic acid (VPA) is a widely used antiepileptic medication.
- Maternal VPA use is linked to adverse pregnancy outcomes, including congenital anomalies and liver toxicity.
- Understanding VPA's impact on fetal development is critical.
Purpose of the Study:
- To investigate the effects of VPA exposure during different pregnancy stages on fetal rat liver gross structure.
- To assess VPA-induced hepatotoxicity in developing rat offspring.
Main Methods:
- Pregnant rats were administered VPA (500 mg/Kg/day IP) during specific gestational trimesters (days 3-5, 8-10, or 16-18).
- A control group received no treatment.
- Fetal livers were examined for gross structural changes on day 21 of gestation.
Main Results:
- Fetal livers from VPA-exposed groups exhibited a significant reduction in weight and relative tissue weight index (RTWI) compared to controls.
- Despite weight changes, the gross appearance of fetal livers remained normal across all groups.
Conclusions:
- Prenatal exposure to VPA during various trimesters induces significant hepatotoxicity in developing rat fetuses.
- The findings underscore the need for cautious VPA prescription during pregnancy due to developmental risks.
Related Concept Videos
01:19Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
948
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
948
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
379
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
379